Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters

Database
Document Type
Language
Clinical aspect
Year range
2.
Int Immunopharmacol ; 96: 107777, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1225264

ABSTRACT

An increasing amount of reports in the literature is showing that medical ozone (O3) is used, with encouraging results, in treating COVID-19 patients, optimizing pain and symptoms relief, respiratory parameters, inflammatory and coagulation markers and the overall health status, so reducing significantly how much time patients underwent hospitalization and intensive care. To date, aside from mechanisms taking into account the ability of O3 to activate a rapid oxidative stress response, by up-regulating antioxidant and scavenging enzymes, no sound hypothesis was addressed to attempt a synopsis of how O3 should act on COVID-19. The knowledge on how O3 works on inflammation and thrombosis mechanisms is of the utmost importance to make physicians endowed with new guns against SARS-CoV2 pandemic. This review tries to address this issue, so to expand the debate in the scientific community.


Subject(s)
COVID-19/drug therapy , Oxidants, Photochemical/pharmacology , Ozone/pharmacology , SARS-CoV-2/drug effects , Humans , Oxidative Stress/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...